Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMark Diagnostics (TSE:BUX)
CNQX:BUX
Holding TSE:BUX?
Track your performance easily
BUX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.18 - C$0.32
Previous CloseC$0.18
Volume94.00K
Average Volume (3M)16.60K
Market Cap
C$16.36M
Enterprise ValueC$16.94M
Total Cash (Recent Filing)C$141.36K
Total Debt (Recent Filing)C$721.96K
Price to Earnings (P/E)―
Beta-0.46
Next Earnings
Nov 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding90,886,229
10 Day Avg. Volume13,087
30 Day Avg. Volume16,602
Standard Deviation0.25
R-Squared0.00186
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-22.00
Price to Sales (P/S)123.59
Price to Cash Flow (P/CF)-15.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioMark Diagnostics News
PremiumCompany Announcements
BioMark Advances in Breast Cancer Detection Technology
PremiumCompany Announcements
BioMark Advances Cancer Detection with Biomarker Study
PremiumCompany Announcements
BioMark Diagnostics Advances Lung Cancer DetectionPremiumCompany Announcements
BioMark Diagnostics Unveils Cancer Detection Tech at Global Conference
PremiumCompany Announcements
BioMark Diagnostics Secures Key Patent in Cancer Diagnostics
PremiumCompany Announcements
BioMark Diagnostics Highlights Glioblastoma Research
PremiumCompany Announcements
BioMark Diagnostics Strategizes with Warrants and OptionsPremiumCompany Announcements
BioMark Secures Funding for Cancer ResearchOptions Prices
Currently, No data available
---
Ownership Overview
BUX FAQ
What was BioMark Diagnostics’s price range in the past 12 months?
BioMark Diagnostics lowest stock price was C$0.18 and its highest was C$0.32 in the past 12 months.
What is BioMark Diagnostics’s market cap?
Currently, no data Available
When is BioMark Diagnostics’s upcoming earnings report date?
BioMark Diagnostics’s upcoming earnings report date is Nov 28, 2024 which is in 5 days.
How were BioMark Diagnostics’s earnings last quarter?
Currently, no data Available
Is BioMark Diagnostics overvalued?
According to Wall Street analysts BioMark Diagnostics’s price is currently Overvalued.
Does BioMark Diagnostics pay dividends?
BioMark Diagnostics does not currently pay dividends.
What is BioMark Diagnostics’s EPS estimate?
BioMark Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioMark Diagnostics have?
BioMark Diagnostics has 90,886,230 shares outstanding.
What happened to BioMark Diagnostics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioMark Diagnostics?
Currently, no hedge funds are holding shares in TSE:BUX
---
BioMark Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
39.22%
Trailing 12-Months
Company Description
BioMark Diagnostics
Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
---
Technical Analysis
Revive Therapeutics
―
Sernova
―
Reliq Health Technologies
―
DMG Blockchain Solutions
―
---